Immunoregulatory functions and therapeutic potential of natural killer cell-derived extracellular vesicles in chronic diseases

• الحاوية / القاعدة: Frontiers in Immunology
• المؤلفون الرئيسيون: Shuang He, Lanqian Su, Haiyang Hu, Haiqi Liu, Jingwen Xiong, Xiangjin Gong, Hao Chi, Qibiao Wu, Guanhu Yang
• التنسيق: مقال
• اللغة: الإنجليزية
• منشور في: Frontiers Media S.A. 2024-01-01
• الموضوعات: NK cell; NK cell-derived exosome; engineered EVs; chronic disease; microvesicles; therapy
• الوصول للمادة أونلاين: https://www.frontiersin.org/articles/10.3389/fimmu.2023.1328094/full

Extracellular vesicles (EVs) have been proven to play a significant immunoregulatory role in many chronic diseases, such as cancer and immune disorders. Among them, EVs derived from NK cells are an essential component of the immune cell functions. These EVs have been demonstrated to carry a variety of toxic proteins and nucleic acids derived from NK cells and play a therapeutic role in diseases like malignancies, liver fibrosis, and lung injury. However, natural NK-derived EVs (NKEVs) have certain limitations in disease treatment, such as low yield and poor targeting. Concurrently, NK cells exhibit characteristics of memory-like NK cells, which have stronger proliferative capacity, increased IFN-γ production, and enhanced cytotoxicity, making them more advantageous for disease treatment. Recent research has shifted its focus towards engineered extracellular vesicles and their potential to improve the efficiency, specificity, and safety of disease treatments. In this review, we will discuss the characteristics of NK-derived EVs and the latest advancements in disease therapy. Specifically, we will compare different cellular sources of NKEVs and explore the current status and prospects of memory-like NK cell-derived EVs and engineered NKEVs.